PCRX (Pacira BioSciences) Volume dana dhuwit perusahaan

Simbol lan logo merek Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences generates revenue through Exparel, overcoming generic pressure via marketing. The company's cash position demonstrates current liquidity, with the value fixed at 0.31. Growth potential is supported by patents for extended-release agents and the complexities of implementing new protocols. Stability is ensured by a strong staff of experts motivated by high compensation and the ethical goals of medicine.

Pacira Pharmaceuticals - Sisa dhuwit perusahaan PCRX (periode 04.07.2022 - 21.11.2026)

Rincian analitis lan laporan data perusahaan Pacira Pharmaceuticals (PCRX)

- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
Analisis kabeh metrik perusahaan:PCRX pacira.com
Produk merek Pacira BioSciences, Inc.

Steady hospital demand for Pacira BioSciences (PCRX) analgesics generates a reliable liquidity inflow, which is reflected in the trend of available cash. By analyzing this cash position chart, an investor assesses the total volume of cash and cash equivalents, allowing for a determination of the balance between the company's financial stability and the efficiency of capital allocation in new projects.

Pesaing utama

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|Sisa dhuwit perusahaan MENS|LGND: Dhuwit awis perusahaan|Sisa dhuwit perusahaan AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Dhuwit awis perusahaan|Alvotech - Sisa dhuwit perusahaan|Dhuwit awis perusahaan LQDA|Galapagos Genomics (GLPG) - Aset likuid perusahaan|Volume dana dhuwit perusahaan ANIP|Dhuwit awis perusahaan Afrezza MNKD|Dana dhuwit perusahaan Amphastar AMPH|SPRY - Dhuwit awis perusahaan|Theravance Biopharma, Inc. - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AQST (Aquestive Therapeutics, Inc.)|SCPH: Volume dana dhuwit perusahaan|Tectonic Therapeutic Inc. - Sisa dhuwit perusahaan|TNXP (Tonix Pharma) - Volume dana dhuwit perusahaan|SXTC: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan EPRX|BHST - Cadangan dhuwit perusahaan|eXoZymes - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan oramed.com ORMP|ENTX - Dana dhuwit perusahaan|Aset likuid perusahaan MindWalk Holdings HYFT|ABVC: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Cumberland Pharmaceuticals Inc.|Dana dhuwit perusahaan Quantum BioPharma Limited|FGEN: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan TELO|Rani Therapeutics Holdings, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Synergy CHC Corp. SNYR|Sisa dhuwit perusahaan RLYB|LEXX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Aptorum|Dhuwit awis perusahaan LYRA|Impact BioMedical Inc - Total volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan TNFA|YCBD - Cadangan dhuwit perusahaan|PainReform Ltd. - Dhuwit awis perusahaan|CYTO (Auris Medical) - Total volume dana dhuwit perusahaan|LIPO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan OPTN (OptiNose)|PIRS: Volume dana dhuwit perusahaan|Procaps Group S.A. (PROC) - Volume dana dhuwit perusahaan|PTPI (Petros Pharma) - Volume dana dhuwit perusahaan|QLI: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan